Multiple Myeloma Therapeutics Market Analysis, By Therapy Type (Chemotherapy And Other Drugs, Radiation, Stem Cell Transplant, Other Supportive Treatments), And Segment Forecasts, 2018 - 2024

Table of Contents

Chapter 1 Research Methodology
                    1.1 Information procurement
                    1.2 Data Analysis
                    1.3 Approaches for market estimation
                       1.3.1 Approach 1: Demand Analysis& Bottom up Approach
                       1.3.2 Approach 2: Top down market estimation
                       1.3.3 Approach 3: Commodity flow and bottom up market estimation
                       1.3.4 Approach 4: KoL perspective based market sizing
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends& Scope
                    4.1 Market segmentation& scope
                       4.1.1 Market Driver Analysis
                       4.1.2 Market Restraint Analysis
                    4.2 Penetration & growth prospect mapping
                    4.3 Multiple Myeloma Therapeutics - SWOT Analysis, By Factor (political & legal, economic and technological)
                    4.4 Industry Analysis - Porter’s
                    4.5 Market Dynamics: Multiple Myeloma Therapeutics
Chapter 5 Market Categorization 1: Therapy Type Estimates & Trend Analysis
                    5.1 Multiple Myeloma Therapeutics Market: Therapy movement analysis
                    5.2 Chemotherapy and other Drugs
                       5.2.1 Chemotherapy and Other drugs market, 2014 - 2024 (USD Million)
                       5.2.2 Traditional Chemotherapy
                             5.2.2.1 Traditional Chemotherapy market, 2014 - 2024 (USD Million)
                       5.2.3 Immunomodulating Agents
                             5.2.3.1 Immunomodulating Agents market, 2014 - 2024 (USD Million)
                       5.2.4 Proteasome inhibitors
                             5.2.4.1 Proteasome inhibitors market, 2014 - 2024 (USD Million)
                       5.2.5 Histone Deacetylase (HDAC) inhibitors
                             5.2.5.1 Histone Deacetylase (HDAC) inhibitors market, 2014 - 2024 (USD Million)
                       5.2.6 Monoclonal Antibodies
                             5.2.6.1 Monoclonal Antibodies market, 2014 - 2024 (USD Million)
                    5.3 Radiation
                       5.3.1 Radiation market, 2014 - 2024 (USD Million)
                    5.4 Stem Cell Transplant andSupportive Treatments
                       5.4.1 Stem Cell Transplant and Supportive treatments market, 2014 - 2024 (USD Million)
Chapter 6 Market Categorization 3: Regional Estimates & Trend Analysis, by therapy type
                    6.1 Multiple Myeloma therapeutics market share by region, 2014& 2020
                    6.2 North America
                       6.2.1 North America multiple myeloma therapeutics market, by therapy type,2014 - 2024 (USD Million)
                       6.2.2 U.S.
                             6.2.2.1 U.S. multiple myeloma therapeutics market,by therapy type, 2014 - 2024 (USD Million)
                       6.2.3 Canada
                             6.2.3.1 Canada multiple myeloma therapeutics market,by therapy type, 2014 - 2024 (USD Million)
                    6.3 Europe
                       6.3.1 Europe multiple myeloma therapeutics market,by therapy type, 2014 - 2024 (USD Million)
                       6.3.2 UK
                             6.3.2.1 UK multiple myeloma therapeutics market,by therapy type, 2014 - 2024 (USD Million)
                       6.3.3 Germany
                             6.3.3.1 Germany multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
                    6.4 Asia Pacific
                       6.4.1 Asia Pacific multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
                       6.4.2 Japan
                             6.4.2.1 Japan multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
                       6.4.3 India
                             6.4.3.1 India multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
                    6.5 Latin America
                       6.5.1 Latin America multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
                       6.5.2 Brazil
                             6.5.2.1 Brazil multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
                       6.5.3 Mexico
                             6.5.3.1 Mexico multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
                    6.6 Middle East and Africa (MEA)
                       6.6.1 MEA multiple myeloma therapeutics market,by therapy type, 2014 - 2024 (USD Million)
                       6.6.2 South Africa
                             6.6.2.1 Africa multiple myeloma therapeutics market,by therapy type, 2014 - 2024 (USD Million)
                       6.6.3 Saudi Arabia
                             6.6.3.1 Saudi Arabia multiple myeloma therapeutics market,by therapy type, 2014 - 2024 (USD Million)
Chapter 7 Competitive Landscape
                    7.1 Janssen Biotech, Inc.
                       7.1.1 Company Overview
                       7.1.2 Financial Performance
                       7.1.3 Product Benchmarking
                       7.1.4 Strategic Initiatives
                    7.2 Bristol-Myers Squibb
                       7.2.1 Company Overview
                       7.2.2 Financial Performance
                       7.2.3 Product Benchmarking
                       7.2.4 Strategic Initiatives
                    7.3 Novartis AG
                       7.3.1 Company Overview
                       7.3.2 Financial Performance
                       7.3.3 Product Benchmarking
                       7.3.4 Strategic Initiatives
                    7.4 Bristol-Myers Squibb Company
                       7.4.1 Company Overview
                       7.4.2 Financial Performance
                       7.4.3 Product Benchmarking
                       7.4.4 Strategic Initiatives
                    7.5 Millennium Pharmaceuticals
                       7.5.1 Company Overview
                       7.5.2 Financial Performance
                       7.5.3 Product Benchmarking
                       7.5.4 Strategic Initiatives
                    7.6 Celgene Corporation
                       7.6.1 Company Overview
                       7.6.2 Financial Performance
                       7.6.3 Product Benchmarking
                       7.6.4 Strategic Initiatives
                    7.7 Kesios Therapeutics Limited
                       7.7.1 Company Overview
                       7.7.2 Financial Performance
                       7.7.3 Product Benchmarking
                       7.7.4 Strategic Initiatives
                    7.8 Amgene, Inc.
                       7.8.1 Company Overview
                       7.8.2 Financial Performance
                       7.8.3 Product Benchmarking
                       7.8.4 Strategic Initiatives
                    7.9 Genzyme Corporation
                       7.9.1 Company Overview
                       7.9.2 Financial Performance
                       7.9.3 Product Benchmarking
                       7.9.4 Strategic Initiatives
                    7.10 Juno Therapeutics
                       7.10.1 Company Overview
                       7.10.2 Financial Performance
                       7.10.3 Product Benchmarking
                       7.10.4 Strategic Initiatives

List of Tables

TABLE 1 North America multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
TABLE 2 North America chemotherapy market, by drug type, 2014 - 2024 (USD Million)
TABLE 3 U.S. multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
TABLE 4 U.S. chemotherapy market, by drug type, 2014 - 2024 (USD Million)
TABLE 5 Canada multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
TABLE 6 Canada chemotherapy market, by drug type, 2014 - 2024 (USD Million)
TABLE 7 Europe multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
TABLE 8 Europe chemotherapy market, by drug type, 2014 - 2024 (USD Million)
TABLE 9 UK multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
TABLE 10 UK chemotherapy market, by drug type, 2014 - 2024 (USD Million)
TABLE 11 Germany multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
TABLE 12 Germany chemotherapy market, by drug type, 2014 - 2024 (USD Million)
TABLE 13 Asia Pacific multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
TABLE 14 Asia Pacific chemotherapy market, by drug type, 2014 - 2024 (USD Million)
TABLE 15 Japan multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
TABLE 16 Japan chemotherapy market, by drug type, 2014 - 2024 (USD Million)
TABLE 17 India multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
TABLE 18 India chemotherapy market, by drug type, 2014 - 2024 (USD Million)
TABLE 19 Latin America multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
TABLE 20 Latin America chemotherapy market, by drug type, 2014 - 2024 (USD Million)
TABLE 21 Brazil multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
TABLE 22 Brazil chemotherapy market, by drug type, 2014 - 2024 (USD Million)
TABLE 23 Mexico multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
TABLE 24 Mexico chemotherapy market, by drug type, 2014 - 2024 (USD Million)
TABLE 25 MEA America multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
TABLE 26 MEA America chemotherapy market, by drug type, 2014 - 2024 (USD Million)
TABLE 27 South Africa multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
TABLE 28 South Africa chemotherapy market, by drug type, 2014 - 2024 (USD Million)
TABLE 29 Saudi Arabia multiple myeloma therapeutics market, by therapy type, 2014 - 2024 (USD Million)
TABLE 30 Saudi Arabia chemotherapy market, by drug type, 2014 - 2024 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary (USD Million)
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Market Dynamics: Multiple Myeloma Therapeutics
FIG. 16 Multiple Myeloma Therapeutics market application outlook key takeaways
FIG. 17 Multiple Myeloma therapeutics: Therapy movement analysis
FIG. 18 Chemotherapy and other drugs market, 2014 - 2024 (USD Million)
FIG. 19 Traditional Chemotherapy market, 2014 - 2024 (USD Million)
FIG. 20 Immunomodulating Agents market, 2014 - 2024 (USD Million)
FIG. 21 Proteasome inhibitors market, 2014 - 2024 (USD Million)
FIG. 22 Histone Deacetylase (HDAC) inhibitors market, 2014 - 2024 (USD Million)
FIG. 23 Monoclonal Antibodies market, 2014 - 2024 (USD Million)
FIG. 24 Radiation market, 2014 - 2024 (USD Million)
FIG. 25 Stem cell transplant and supportive treatment market, 2014 - 2024 (USD Million)
FIG. 26 Regional market place: Key takeaways
FIG. 27 Regional outlook, 2014 & 2020